PAVmed (PAVM) News Today $1.55 -0.16 (-9.36%) (As of 03:58 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 11 at 9:06 AM | ca.finance.yahoo.comPAVmed Inc. (PAVM) Interactive Stock Chart - Yahoo FinanceSeptember 11 at 5:07 AM | americanbankingnews.comPAVmed (NASDAQ:PAVM) Price Target Cut to $21.00 by Analysts at Ascendiant Capital MarketsSeptember 10 at 7:56 AM | prnewswire.comLucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressSeptember 3, 2024 | prnewswire.comLucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthAugust 20, 2024 | prnewswire.comLucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerAugust 15, 2024 | finance.yahoo.comPAVmed Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 14, 2024 | msn.comTalks continue over train drivers’ pay disputeAugust 13, 2024 | msn.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | finance.yahoo.comPAVmed Provides Business Update and Second Quarter 2024 Financial ResultsAugust 13, 2024 | prnewswire.comThe American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerAugust 12, 2024 | markets.businessinsider.comHere's what Wall Street expects from PAVmed's earnings reportAugust 12, 2024 | msn.comPAVmed Q2 2024 Earnings PreviewAugust 8, 2024 | prnewswire.comLucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventAugust 6, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingAugust 5, 2024 | prnewswire.comLucid Diagnostics to Participate in Upcoming Investor ConferencesJuly 29, 2024 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024July 23, 2024 | prnewswire.comLucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeJuly 11, 2024 | prnewswire.comLucid Diagnostics Launches New Corporate WebsiteJuly 2, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationJune 13, 2024 | prnewswire.comPAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteJune 12, 2024 | prnewswire.com4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingMay 18, 2024 | finanznachrichten.dePAVmed Inc.: PAVmed Provides Business Update and First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comPAVmed Inc (PAVM) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...May 13, 2024 | prnewswire.comPAVmed Provides Business Update and First Quarter 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comLegacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallMay 7, 2024 | prnewswire.comLucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsMay 3, 2024 | prnewswire.comPAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024May 2, 2024 | finance.yahoo.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024May 2, 2024 | prnewswire.comLucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingMay 1, 2024 | finance.yahoo.comVeris teams up with Ohio University for cancer digital health pilotApril 30, 2024 | prnewswire.comPAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteApril 29, 2024 | finance.yahoo.comInnovations in Cardiac Care: The Future of Cardiac Ablation Devices RevealedApril 29, 2024 | prnewswire.comLucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthApril 17, 2024 | msn.comPAVmed (PAVM) Price Target Decreased by 8.51% to 10.97April 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for PAVmed on Growth and Valuation Prospects Amidst Product CommercializationMarch 29, 2024 | seekingalpha.comPAVmed Inc. (PAVM) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | markets.businessinsider.comBuy Rating Affirmed for PAVmed with Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price TargetMarch 28, 2024 | finance.yahoo.comQ4 2023 PAVmed Inc Earnings CallMarch 27, 2024 | finance.yahoo.comPAVmed Full Year 2023 Earnings: EPS Beats ExpectationsMarch 26, 2024 | prnewswire.comPAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsMarch 25, 2024 | markets.businessinsider.comWhat Wall Street expects from PAVmed's earningsMarch 25, 2024 | tmcnet.comNovosound secures patent for wireless wearable ultrasound imaging platformMarch 21, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationMarch 21, 2024 | prnewswire.comPAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpXMarch 13, 2024 | prnewswire.comPAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024March 12, 2024 | finance.yahoo.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024March 2, 2024 | morningstar.comPAVmed Inc PAVMFebruary 29, 2024 | finance.yahoo.comPAVmed Inc.'s (NASDAQ:PAVM) Intrinsic Value Is Potentially 66% Above Its Share PriceFebruary 22, 2024 | benzinga.comPAVmed Stock (NASDAQ:PAVM) Dividends: History, Yield and DatesFebruary 16, 2024 | finance.yahoo.comLucid Diagnostics Provides Update Regarding World Trade Center Health Program Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Place this $0.99 trade BEFORE the election (Ad)Earlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands of traders and placed a unique trade that surged 1,129% in just 2 days... All using a unique trade that cost him less than $0.99 trade. Click here to RSVP to today's FREE training >>> PAVM Media Mentions By Week PAVM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PAVM News Sentiment▼-0.330.44▲Average Medical News Sentiment PAVM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PAVM Articles This Week▼41▲PAVM Articles Average Week Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Allurion Technologies News Today Lucid Diagnostics News Today Co-Diagnostics News Today iCAD News Today electroCore News Today Precision Optics News Today IRIDEX News Today ReWalk Robotics News Today SurgePays News Today Outset Medical News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PAVM) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersPreferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stockThis company, known for its autonomous robotic surgical systems, completed a crowd-funded public offering and ...Deal Maker | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviat...Market JAR | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredNatural is heading to the NasdaqNatural solutions are already better for the environment. But there’s one company taking it a step further: Th...MedX | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
